CanSino's Covid-19 vaccine candidate approved for military use in China

No vaccine has yet been approved for commercial use against the illness caused by the new coronavirus. - Reuters

BEIJING (Reuters): China's military has received the green light to use a Covid-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday (June 29).

The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada.